Researchers are exploring the use of islet organoids, which may involve the use of stem cells and endothelial cells, as a potential new approach for islet transplantation in diabetes treatment. This area of research appears to hold promise for the treatment of type 1 diabetes, with some studies suggesting it could potentially repair damage to the pancreas. The development of this treatment is being supported by various research partnerships and grants, although the specifics of the treatment and its potential outcomes are still being studied.